D.E. Shaw & Co
UTMD icon

D.E. Shaw & Co’s Utah Medical Products UTMD Stock Holding History

D.E. Shaw & Co’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$541K Sell
8,735
-100
-1% -$6.3K ﹤0.01% 3816
2025
Q4 		$494K Sell
8,835
-346
-4% -$20.1K ﹤0.01% 3935
2025
Q3 		$578K Sell
9,181
-106
-1% -$6.27K ﹤0.01% 3792
2025
Q2 		$529K Sell
9,287
-421
-4% -$22.9K ﹤0.01% 3615
2025
Q1 		$544K Hold
9,708
– – ﹤0.01% 3459
2024
Q4 		$597K Sell
9,708
-405
-4% -$26.2K ﹤0.01% 3508
2024
Q3 		$677K Sell
10,113
-674
-6% -$45.8K ﹤0.01% 3522
2024
Q2 		$721K Sell
10,787
-5,464
-34% -$372K ﹤0.01% 3396
2024
Q1 		$1.16M Buy
16,251
+11,747
+261% +$881K ﹤0.01% 3000
2023
Q4 		$379K Sell
4,504
-212
-4% -$17.6K ﹤0.01% 3645
2023
Q3 		$406K Buy
4,716
+1,886
+67% +$174K ﹤0.01% 3505
2023
Q2 		$264K Buy
2,830
+442
+19% +$41.6K ﹤0.01% 3644
2023
Q1 		$226K Buy
2,388
+300
+14% +$27.6K ﹤0.01% 3853
2022
Q4 		$210K Buy
+2,088
New +$191K ﹤0.01% 4231
2022
Q2 		– Sell
-2,831
Closed -$254K – 5798
2022
Q1 		$254K Buy
+2,831
New +$260K ﹤0.01% 4739

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co's UTMD Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Utah Medical Products (UTMD) stake by 1.1% in Q1 2026, selling an estimated $6.3K and leaving 8,735 shares worth $541K. The position accounts for ﹤0.01% of the portfolio, ranked #3816.

D.E. Shaw & Co first reported a position in UTMD in Q1 2022 and has held it in 15 quarters since. The position peaked at $1.16M in Q1 2024. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.

  • D.E. Shaw & Co held 8,735 shares of Utah Medical Products worth $541K as of Q1 2026.
  • D.E. Shaw & Co sold 100 Utah Medical Products shares in Q1 2026, an estimated $6.3K.
  • Utah Medical Products made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #3816 holding.
  • D.E. Shaw & Co first reported a position in Utah Medical Products in Q1 2022 and has held it in 15 quarters since.
  • D.E. Shaw & Co's Utah Medical Products position peaked at $1.16M in Q1 2024.
  • 119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.